ZA200205193B - Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl. - Google Patents

Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.

Info

Publication number
ZA200205193B
ZA200205193B ZA200205193A ZA200205193A ZA200205193B ZA 200205193 B ZA200205193 B ZA 200205193B ZA 200205193 A ZA200205193 A ZA 200205193A ZA 200205193 A ZA200205193 A ZA 200205193A ZA 200205193 B ZA200205193 B ZA 200205193B
Authority
ZA
South Africa
Prior art keywords
dimethylaminomethyl
hydroxycyclohexyl
hydroxybenzoate
phenyl
esters derived
Prior art date
Application number
ZA200205193A
Other languages
English (en)
Inventor
Juan Huguet Clotet
Marisabel Mourelle Mancini
Elisabet De Ramon Amat
Original Assignee
Vita Invest Sa
Merger Lab Vita S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa, Merger Lab Vita S A filed Critical Vita Invest Sa
Publication of ZA200205193B publication Critical patent/ZA200205193B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200205193A 1999-12-30 2002-06-27 Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl. ZA200205193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000060A ES2160534B1 (es) 1999-12-30 1999-12-30 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.

Publications (1)

Publication Number Publication Date
ZA200205193B true ZA200205193B (en) 2003-06-27

Family

ID=8491916

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205193A ZA200205193B (en) 1999-12-30 2002-06-27 Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.

Country Status (30)

Country Link
US (1) US6894076B2 (pl)
EP (1) EP1251120B1 (pl)
JP (1) JP2003519208A (pl)
KR (1) KR20020063281A (pl)
CN (1) CN1414946A (pl)
AP (1) AP1234A (pl)
AT (1) ATE284380T1 (pl)
AU (1) AU775918B2 (pl)
BG (1) BG106883A (pl)
BR (1) BR0016882A (pl)
CA (1) CA2395976A1 (pl)
CZ (1) CZ20022189A3 (pl)
DE (1) DE60016631D1 (pl)
EA (1) EA004770B1 (pl)
EE (1) EE200200365A (pl)
ES (1) ES2160534B1 (pl)
HR (1) HRP20020559A2 (pl)
HU (1) HUP0204147A3 (pl)
IL (1) IL150392A0 (pl)
IS (1) IS6440A (pl)
MA (1) MA26862A1 (pl)
MX (1) MXPA02006514A (pl)
NO (1) NO20023098D0 (pl)
NZ (1) NZ520263A (pl)
OA (1) OA12132A (pl)
PL (1) PL356056A1 (pl)
SK (1) SK9252002A3 (pl)
WO (1) WO2001049650A1 (pl)
YU (1) YU50902A (pl)
ZA (1) ZA200205193B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
EP2383255A1 (en) 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
CN103179954A (zh) 2010-09-02 2013-06-26 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
HUE048032T2 (hu) 2015-10-15 2020-05-28 Jiangsu Hengrui Medicine Co Oxaspiro-származék, elõállítási eljárása és alkalmazásai gyógyszerekben

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3562589A (en) * 1968-09-09 1971-02-09 Ite Imperial Corp Electrically resetting undervoltage trip for circuit breakers
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
GB9924604D0 (en) * 1999-10-18 1999-12-22 European Molecular Biology Lab Embl Genetic switch

Also Published As

Publication number Publication date
JP2003519208A (ja) 2003-06-17
IS6440A (is) 2002-06-25
NO20023098L (no) 2002-06-26
EE200200365A (et) 2003-10-15
EA004770B1 (ru) 2004-08-26
US6894076B2 (en) 2005-05-17
YU50902A (sh) 2006-01-16
OA12132A (en) 2006-05-05
EP1251120A1 (en) 2002-10-23
NZ520263A (en) 2004-07-30
HUP0204147A2 (hu) 2003-04-28
MXPA02006514A (es) 2004-07-30
AU2012601A (en) 2001-07-16
EA200200614A1 (ru) 2002-12-26
KR20020063281A (ko) 2002-08-01
DE60016631D1 (de) 2005-01-13
CZ20022189A3 (cs) 2003-03-12
ES2160534A1 (es) 2001-11-01
SK9252002A3 (en) 2003-04-01
BG106883A (en) 2003-05-30
US20030100598A1 (en) 2003-05-29
BR0016882A (pt) 2002-11-05
HUP0204147A3 (en) 2003-10-28
EP1251120B1 (en) 2004-12-08
AP2002002571A0 (en) 2002-09-30
NO20023098D0 (no) 2002-06-26
ES2160534B1 (es) 2002-04-16
IL150392A0 (en) 2002-12-01
AP1234A (en) 2003-12-28
HRP20020559A2 (en) 2004-02-29
MA26862A1 (fr) 2004-12-20
ATE284380T1 (de) 2004-12-15
AU775918B2 (en) 2004-08-19
CA2395976A1 (en) 2001-07-12
PL356056A1 (pl) 2004-06-14
CN1414946A (zh) 2003-04-30
WO2001049650A1 (es) 2001-07-12

Similar Documents

Publication Publication Date Title
ZA200205193B (en) Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.
ZA200110179B (en) Process for the preparation of pure citalopram.
ZA200108855B (en) Method for the preparation of citalopram.
ZA200108854B (en) Method for the preparation of citalopram.
ZA200108248B (en) Antiperspirant compositions.
AU2541500A (en) Use of 3-(2,4,6-trimethylphenyl)- 4-neopentylcarbonyloxy- 5,5- tetr amethylene-delta3- dihydrofurane-2- on for controlling the white fly
AU6432800A (en) Process for the synthesis of citalopram
AU2224100A (en) Conga shell protector
HK1042036A1 (zh) 钙溶解化合物
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
ZA200107863B (en) Candle composition.
AU1172800A (en) Cyclocarbonate groups containing hydroxyamine oligomers from epoxycyclocarbonates
CA2213810A1 (en) Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
EG24052A (en) Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
IL149507A0 (en) 3-(4,5-dihydroisoxazole-5-yl) benzoylpyrazole
MXPA02000261A (es) Aminoindanos novedosos.
GB0029650D0 (en) Proces for the preparation of 1,1-cyclopropanedicarboxylic diesters
EP1072296A3 (en) Video game
MXPA03005965A (es) Composicion farmaceutica que contiene citalopram.
AU7512400A (en) Hardness stabilization by mercaptopyridines
IL144063A0 (en) Process for the preparation of 1,1-cyclohexanediacetic acid
FR2789448B1 (fr) Helice, notamment pour groupe moto-ventilateur
AU2669001A (en) Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substitued benzoylpyrazoles
ZA200201714B (en) Novel compound F-15078.
AU2001293843A1 (en) 19-nor-17alpha-pregna-1,3,5 (10)-trien-17beta-ols of 21,16alpha-lactone ring